Biogen Pharmachem Industries Ltd

Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the Board of Directors of the Company in their meeting held on today i.e. Friday 07th November 2025 at the Registered Office of the Company and transacted the following major businesses: 1.) Considered and approved Un-audited financial results for the quarter and half year ended as on 30th September 2025.The board meeting commented at 03:30 PM and concluded at 04:00 PMPlease take the above intimation in your records.Thanking You.